Market by Product Type, Gender, Application, End-user, and Country Outlook | Forecast 2023-2030
Based on Triton Market Research’s report, the botulinum toxin market in Latin America is estimated to register a compound annual growth rate of 10.11% during the forecasted period from 2023 to 2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries assessed in the region are:
•
Brazil
•
Mexico
•
Rest of Latin America
In
Latin America, non-invasive cosmetic treatments have gained considerable
popularity due to their minimized downtime, absence of scarring, cost-effectiveness,
enhanced precision, and reduced likelihood of complications in comparison to
open procedures. Additionally, the decreased post-treatment downtime
contributes significantly to the increasing favorability of non-invasive
techniques. As a result, these factors are widening the scope of the botulinum
toxin market across the region.
Brazil holds the majority of share
in the region’s market.
The nation’s market is propelled by the growing adoption of
minimally invasive cosmetic procedures. In this regard, leading formulations of
botulinum toxin type A, such as Botox, Dysport, Xeomin, Prosigne, and Botulift,
are available in Brazil. Additionally, the nation’s market is anticipated to
witness substantial influence due to the involvement of major stakeholders. For
instance, in February 2020, Daewoong Pharma obtained authorization from Brazil’s
Agencia Nacional de Vigilancia Sanitaria (ANVISA) for utilizing botulinum toxin
in treating wrinkles between the eyebrows and post-stroke stiffness in upper limb
muscles. Such strategic initiatives drive the botulinum toxin market’s growth.
Dermatologists
are specialized medical practitioners who address ailments related to the skin,
hair, and nails. Over the past decade, there has been a notable increase in the
prevalence of cosmetic treatments. Minimally invasive methods have gained even
greater popularity compared to surgical interventions, resulting in the rise of
specialty and dermatology clinics. The
market’s growth is assessed based on end-user, gender, application, and product
type. The end-user category is branched into specialty and dermatology
clinics, hospitals and clinics, and other end-users.
Some of the major companies
thriving in the market include Hugel Inc, Candela Medical Corporation, Revance Therapeutics
Inc, US WorldMeds LLC, and Merz Pharma GmbH & Co KGaA.
Hugel
Inc is a pharmaceutical company involved in the production of
biopharmaceuticals. Its product line offers hyaluronic acid designed for the
momentary reduction of facial wrinkles. Its offering also includes Botulax,
which provides a solution for the temporary improvement of severe lasso
wrinkles. The company distributes its products across multiple regions,
including Latin America.
Key deliverables of the report:
·
Market
CAGR during the forecasting years 2023-2030
·
Detailed
data highlighting key insights, industry components, and market strategies
·
Comprehensive
information and estimation of the botulinum toxin market revenue growth in
Latin America and its influence on the parent market
·
In-depth
study of forthcoming trends in consumer behavioral patterns
·
A
meticulous analysis of the competitive landscape, vendor scorecard, and
Porter’s Five Forces
·
A
wide-ranging study of factors that will challenge the LA botulinum toxin market’s
growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT1. LATIN
AMERICA BOTULINUM TOXIN MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE BOTULINUM TOXIN MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHTS
2.2.1. GROWING
DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
2.2.2. SURGE
IN DEMAND FOR BOTULINUM TOXIN AMONG MILLENNIALS
AND
GEN-Z
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. REGULATORY
FRAMEWORK
2.5. KEY
MARKET STRATEGIES
2.5.1. PRODUCT
LAUNCHES
2.5.2. COLLABORATIONS
2.5.3. BUSINESS
EXPANSIONS & DIVESTITURES
2.5.4. ACQUISITIONS
2.6. MARKET
DRIVERS
2.6.1. SURGE
IN DEMAND FOR AESTHETIC PROCEDURES
2.6.2. RISE
IN GERIATRIC POPULATION
2.7. MARKET
CHALLENGES
2.7.1. LIMITED
REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
2.7.2. ADVERSE
EFFECTS OF BOTULINUM TOXIN
2.7.3. EMERGING
PROBLEM OF BOTULINUM TOXIN TYPE A RESISTANCE
2.8. MARKET
OPPORTUNITIES
2.8.1. EXPANSION
OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
2.8.2. RISING
MEDICAL TOURISM
2.9. ANALYST
PERSPECTIVE
3. LATIN
AMERICA BOTULINUM TOXIN MARKET OUTLOOK - BY PRODUCT TYPE
3.1. TYPE A
BOTULINUM TOXIN
3.2. TYPE B
BOTULINUM TOXIN
4. LATIN
AMERICA BOTULINUM TOXIN MARKET OUTLOOK - BY GENDER
4.1. WOMEN
4.2. MEN
5. LATIN
AMERICA BOTULINUM TOXIN MARKET OUTLOOK - BY APPLICATION
5.1. AESTHETIC
5.1.1. CROW’S
FEET
5.1.2. FOREHEAD
LINES
5.1.3. FROWN
LINES/GLABELLAR
5.1.4. SQUARE
JAW/MASSETER
5.1.5. OTHER
AESTHETIC APPLICATIONS
5.2. MEDICAL
5.2.1. CHRONIC
MIGRAINE
5.2.2. MUSCLE
SPASM
5.2.3. OVERACTIVE
BLADDER
5.2.4. HYPERHIDROSIS
5.2.5. OTHER
MEDICAL APPLICATIONS
6. LATIN
AMERICA BOTULINUM TOXIN MARKET OUTLOOK - BY END-USER
6.1. SPECIALTY
AND DERMATOLOGY CLINICS
6.2. HOSPITALS
AND CLINICS
6.3. OTHER
END-USERS
7. LATIN
AMERICA BOTULINUM TOXIN MARKET – BY COUNTRY OUTLOOK
7.1. LATIN
AMERICA
7.1.1. MARKET
BY TYPE
7.1.2. MARKET
BY GENDER
7.1.3. MARKET
BY APPLICATION
7.1.3.1. MARKET
BY AESTHETIC
7.1.3.2. MARKET
BY MEDICAL
7.1.4. MARKET
BY END-USER
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. BRAZIL
7.1.5.1.1. BRAZIL
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.2. MEXICO
7.1.5.2.1. MEXICO
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.3. REST
OF LATIN AMERICA
7.1.5.3.1. REST
OF LATIN AMERICA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. ABBVIE
INC
8.1.1. OVERVIEW
8.1.2. PRODUCT
PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. EVOLUS
INC
8.2.1. OVERVIEW
8.2.2. PRODUCT
PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. MEDYTOX
INC
8.3.1. OVERVIEW
8.3.2. PRODUCT
PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. LANZHOU
INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
8.4.1. OVERVIEW
8.4.2. PRODUCT
PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. DAEWOONG
PHARMACEUTICAL CO LTD
8.5.1. OVERVIEW
8.5.2. PRODUCT
PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. GALDERMA
SA
8.6.1. OVERVIEW
8.6.2. PRODUCT
PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. IPSEN
PHARMA
8.7.1. OVERVIEW
8.7.2. PRODUCT
PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. HUGEL
INC
8.8.1. OVERVIEW
8.8.2. PRODUCT
PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. CANDELA
MEDICAL CORPORATION
8.9.1. OVERVIEW
8.9.2. PRODUCT
PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. MERZ
PHARMA GMBH & CO KGAA
8.10.1. OVERVIEW
8.10.2. PRODUCT
PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. REVANCE
THERAPEUTICS INC
8.11.1. OVERVIEW
8.11.2. PRODUCT
PORTFOLIO
8.12. US
WORLDMEDS LLC
8.12.1. OVERVIEW
8.12.2. PRODUCT
PORTFOLIO
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: LATIN AMERICA
REGULATORY FRAMEWORK FOR BOTULINUM TOXIN
TABLE 3: LIST OF PRODUCT
LAUNCHES
TABLE 4: LIST OF
COLLABORATIONS
TABLE 5: LIST OF BUSINESS
EXPANSIONS & DIVESTITURES
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLE OF
COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES
TABLE 8: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $ MILLION)
TABLE 10: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE 11: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
TABLE 12: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
TABLE 13: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 14: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE
1: LATIN AMERICA BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN
%)
FIGURE
2: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2030
(IN $ MILLION)
FIGURE
3: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2030
(IN $ MILLION)
FIGURE
4: LATIN AMERICA BOTULINUM TOXIN MARKET, BY GENDER, 2022 & 2030 (IN %)
FIGURE
5: LATIN AMERICA BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2030 (IN $ MILLION)
FIGURE
6: LATIN AMERICA BOTULINUM TOXIN MARKET, BY MEN, 2023-2030 (IN $ MILLION)
FIGURE
7: LATIN AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2022 & 2030 (IN %)
FIGURE
8: LATIN AMERICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
FIGURE
9: LATIN AMERICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2022 & 2030 (IN %)
FIGURE
10: LATIN AMERICA BOTULINUM TOXIN MARKET, BY CROW’S FEET, 2023-2030 (IN $
MILLION)
FIGURE
11: LATIN AMERICA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2030 (IN $
MILLION)
FIGURE
12: LATIN AMERICA BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2030
(IN $ MILLION)
FIGURE
13: LATIN AMERICA BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2030 (IN
$ MILLION)
FIGURE
14: LATIN AMERICA BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS,
2023-2030 (IN $ MILLION)
FIGURE
15: LATIN AMERICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
FIGURE
16: LATIN AMERICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2022 & 2030 (IN %)
FIGURE
17: LATIN AMERICA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2030 (IN $
MILLION)
FIGURE
18: LATIN AMERICA BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2030 (IN $
MILLION)
FIGURE
19: LATIN AMERICA BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2030 (IN
$ MILLION)
FIGURE
20: LATIN AMERICA BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2030 (IN $ MILLION)
FIGURE
21: LATIN AMERICA BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS,
2023-2030 (IN $ MILLION)
FIGURE
22: LATIN AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE
23: LATIN AMERICA BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS,
2023-2030 (IN $ MILLION)
FIGURE
24: LATIN AMERICA BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2030
(IN $ MILLION)
FIGURE
25: LATIN AMERICA BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2030 (IN $
MILLION)
FIGURE
26: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2022 & 2030
(IN %)
FIGURE
27: BRAZIL BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE
28: MEXICO BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE
29: REST OF LATIN AMERICA BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)